Pharmacist Intervention for High Cholesterol

Overseen By Lyndsi Roland, PharmD

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: Wake Forest University Health Sciences

Disqualifiers: Women of childbearing age, Hospice, End-stage liver disease, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

Duration: 5 months

80 Participants Needed

What You Need to Know Before You Apply

What is the purpose of this trial?

The primary objective of this research project is to compare the effect of pharmacist interventions versus usual care in the implementation of guideline directed lipid lowering therapies for secondary prevention.

Who Is on the Research Team?

Kayla Marvin, PharmD

Principal Investigator

Wake Forest University Health Sciences

Are You a Good Fit for This Trial?

This trial is for patients with coronary artery disease and high LDL cholesterol levels (>55), who are currently seeing a primary care physician at one of six specific clinics. It excludes women who could become pregnant, those managed by other practices, hospice or long-term care residents, and individuals with end-stage liver disease.

Inclusion Criteria

I have been diagnosed with coronary artery disease.

LDL > 55

Primary Care Physician at 1 of 6 identified clinics

Exclusion Criteria

Patients who are no longer an active patient of one of the internal medicine practices

Patients whose cholesterol is managed by another practice

I am a woman who could become pregnant.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Pharmacist review of patient chart and follow-up visits to prescribe appropriate therapy for hyperlipidemia

5 months

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

• Pharmacist Intervention in lipid therapy

Trial Overview The study aims to compare the effectiveness of pharmacist-led interventions in managing cholesterol using guideline-directed therapies versus usual care without this specialized intervention for secondary prevention in very high-risk patients.

How Is the Trial Designed?

Group I: Pharmacist Intervention Experimental Treatment 1 Intervention

Pharmacist review of patient chart and follow up visits to prescribe appropriate therapy for hyperlipidemia.

Group II: Control Active Control 1 Intervention

Chart review only

Who Is Running the Clinical Trial?

Wake Forest University Health Sciences

Lead Sponsor

Trials

1,432

Recruited

2,506,000+